Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?

0 avis

Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?

Archive ouverte

Edité par CCSD ; American Association for Clinical Chemistry -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

Archive ouverte | Bal, Antonin | CCSD

International audience. A comprehensive clinical and microbiological assessments of COVID-19 in front-line healthcare workers (HCWs) is needed. Between April 10th and May 28th, 2020, 319 HCWs with acute illness were...

Publisher correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

Archive ouverte | Bal, Antonin | CCSD

International audience

Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

Archive ouverte | Bal, Antonin | CCSD

International audience. Abstract A comprehensive clinical and microbiological assessments of COVID-19 in front-line healthcare workers (HCWs) is needed. Between April 10th and May 28th, 2020, 319 HCWs with acute ill...

Chargement des enrichissements...